Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study
Authors:
- Mario PoljakMPMario Poljak
- Irena KlavsIKIrena Klavs
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer ScreeningJournal of Clinical Microbiology, 2011
- Global Proficiency Study of Human Papillomavirus GenotypingJournal of Clinical Microbiology, 2010
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Impact of Improved Classification on the Association of Human Papillomavirus With Cervical PrecancerAmerican Journal of Epidemiology, 2009
- HPV infection in EuropeEuropean Journal of Cancer, 2009
- Challenges in starting organised screening programmes for cervical cancer in the new member states of the European UnionEuropean Journal of Cancer, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- Chapter 1: HPV in the etiology of human cancerVaccine, 2006